Lv4
494 积分 2021-08-16 加入
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
3天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
4天前
已完结
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
5天前
已关闭
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
6天前
已关闭
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
6天前
已完结
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
6天前
已关闭
Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis
6天前
已关闭
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
7天前
已完结
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
7天前
已完结
Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial
8天前
已关闭
皖公网安备34019202002308
